myirislogo
27 November, 2014 15:58 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
I T C 360.75 0.70
Hindalco In 172.65 2.07
State Bank O 305.85 0.11
Bhel 283.00 4.35
Axis Bank 468.00 0.37
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Pfizer Limited
Pfizer Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500680NSE:PFIZERBloomberg:PFIZ@INReuters:PFIZ.BO
Market Lot: 1Face Value: 10ISIN Demat: INE182A01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
25-NOV-13 The board of the directors of Pfizer (`Pfizer India) and Wyeth (Wyeth India) in their respective meetings have approved a proposal to merge Wyeth India with Pfizer India. 25-NOV-13 Pfizer, the research-based pharmaceutical company, announced that the board of directors has approved the payment of interim dividend of Rs 360 equity share of Rs 10 each (3600%) to the shareholders of the company. The said interim dividend will be paid on...   More..
Business Profile Future Plans
One To One
Face To Face
We would like to grow above the market and have a whole lot of strategies. We are looking at alliances, brands, lucrative products, line extensions, new delivery systems  Kewal Handa ,finance director
Recent news
Latest News
Pfizer standalone quarterly profit declines 3.66%   -IRIS 05-May-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Sep-2014(6)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 5093.0010042.709479.80
Other Income200.601093.801052.40
Total Income5293.6011136.5010532.20
Cost of goods sold4502.708732.708629.80
OPBDIT790.902403.801902.40
PAT343.202208.505032.00
Gross Block---
Equity capital298.40298.40298.40
EPS (Rs.)-74.01168.63
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-13.31 - 24.045.92 - 8.36
Debt / Equity (x)---
Operating margin (% of OI)14.921.618.1
Net margin (% of OI) 6.519.847.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Pfizer Centre
Patel Estate
Off S V Road
Jogeshwari (West)
Mumbai
Maharashtra-400 102
PHONE
(022) 6693 2000
FAX
(022) 2678 4569
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer